Biovica International AB Share Price
Equities
BIOVIC B
SE0008613731
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.706 SEK | +6.36% | -22.81% | -33.88% |
04-13 | Certain B Shares of Biovica International AB are subject to a Lock-Up Agreement Ending on 13-APR-2024. | CI |
04-12 | Biovica International AB Announces Divitum® Tka in Observational Trial | CI |
Sales 2024 * | 10M 914K 73.15M | Sales 2025 * | 116M 10.6M 849M | Capitalization | 143M 13.11M 1.05B |
---|---|---|---|---|---|
Net income 2024 * | -110M -10.05M -805M | Net income 2025 * | -51M -4.66M -373M | EV / Sales 2024 * | 5.99 x |
Net cash position 2024 * | 83.5M 7.63M 611M | Net cash position 2025 * | 43.01M 3.93M 315M | EV / Sales 2025 * | 0.87 x |
P/E ratio 2024 * |
-0.13
x | P/E ratio 2025 * |
-0.57
x | Employees | 37 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.54% |
Latest transcript on Biovica International AB
1 day | +6.36% | ||
1 week | -22.81% | ||
Current month | -30.65% | ||
1 month | -32.44% | ||
3 months | -33.36% | ||
6 months | -36.10% | ||
Current year | -33.88% |
Managers | Title | Age | Since |
---|---|---|---|
Anders Rylander
CEO | Chief Executive Officer | 54 | 31/12/09 |
Anders Morén
DFI | Director of Finance/CFO | 59 | 31/12/22 |
Hanna Ritzen
CTO | Chief Tech/Sci/R&D Officer | 45 | 31/12/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 64 | 19/03/19 | |
Annika Berg
BRD | Director/Board Member | 61 | 31/12/19 |
Maria Holmlund
BRD | Director/Board Member | 68 | 31/12/15 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.706 | +6.36% | 139,425 |
25/04/24 | 1.604 | -4.30% | 404,389 |
24/04/24 | 1.676 | -11.79% | 1,593,983 |
23/04/24 | 1.9 | -7.77% | 464,098 |
22/04/24 | 2.06 | -6.79% | 302,655 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 04:29 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.88% | 13.08M | |
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
-46.94% | 377M |
- Stock Market
- Equities
- BIOVIC B Stock